Navigation Links
Genaera Corporation Announces MSI-1436 Data Presented at Society of Neuroscience Meeting
Date:3/28/2008

- Preclinical Data Indicates MSI-1436 Does Not Alter Rate of Dopamine

Uptake -

PLYMOUTH MEETING, Pa., March 28 /PRNewswire-FirstCall/ -- Genaera Corporation (Nasdaq: GENR) announced that preclinical data was presented Thursday at the Chicago Chapter of the Society of Neuroscience by Mitchell F. Roitman, Ph.D., a Genaera collaborator and investigator with the University of Illinois at Chicago. The abstract titled "A novel anti-obesity drug MSI-1436 does not alter the rate of dopamine uptake via the dopamine transporter," demonstrates that MSI-1436 does not inhibit the dopamine transporter in vivo by directly measuring dopamine levels in the brain of rats after MSI-1436 administration.

Dopamine is a neurotransmitter found in the brain which can have affects on locomotor function and addictive behavior. Many drugs that reduce food intake and body weight affect the rate of dopamine reuptake by inhibiting the dopamine transporter (DAT), such as amphetamine and bupropion. Such compounds, which inhibit the dopamine transporter, are considered undesirable as weight- loss drugs since they affect locomotor behavior and may have high addictive potential. MSI-1436 is a protein tyrosine phosphatase 1B inhibitor (PTP-1B), which increases insulin sensitivity and reduces food intake in animals, and is currently in clinical development for anti-obesity and anti-diabetes therapy. Preliminary in vitro studies in cells suggested that MSI-1436 may interact with the dopamine transporter but in vivo behavioral tests in rats did not show DAT-inhibitory activity. Therefore, a definitive study to resolve this discrepancy was designed.

The effects of MSI-1436 on dopamine reuptake were investigated using in viv
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
3. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
6. Genaera Begins Dosing Second Phase 1 Trial of Type 2 Diabetes and Obesity Compound Trodusquemine (MSI-1436)
7. Genaera Announces Diabetes IND In Effect for Trodusquemine (MSI-1436)
8. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... -- Endo International plc (NASDAQ: ENDP ) (TSX: ... acquire all of the outstanding shares of Auxilium Pharmaceuticals, Inc. ... of $28.10 in a cash and stock transaction valued at ... 31% to Auxilium,s closing price on September 16, 2014 and ... shares for the previous 30 days.  Under the terms of ...
(Date:9/16/2014)... Sept. 16, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... is commencing an underwritten registered public offering of ... shares are being offered by Aratana Therapeutics. ... as joint book-running managers for the offering.  ...
(Date:9/16/2014)... This report analyzes the worldwide markets for Foot Care Products ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2013 through ... markets. Market data and analytics are derived from primary and ...
Breaking Medicine Technology:Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 2Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 3Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 4Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 5Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 6Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock 7Aratana Therapeutics, Inc. Announces Proposed Public Offering 2Global Foot Care Products Industry 2Global Foot Care Products Industry 3Global Foot Care Products Industry 4Global Foot Care Products Industry 5Global Foot Care Products Industry 6Global Foot Care Products Industry 7Global Foot Care Products Industry 8Global Foot Care Products Industry 9Global Foot Care Products Industry 10Global Foot Care Products Industry 11Global Foot Care Products Industry 12Global Foot Care Products Industry 13Global Foot Care Products Industry 14Global Foot Care Products Industry 15Global Foot Care Products Industry 16Global Foot Care Products Industry 17Global Foot Care Products Industry 18Global Foot Care Products Industry 19Global Foot Care Products Industry 20Global Foot Care Products Industry 21Global Foot Care Products Industry 22
(Date:9/17/2014)... Colo. (PRWEB) September 17, 2014 In ... Sentinel University offers tips to health IT professionals for ... , A recent study by HIMSS shows demand for ... and a candidate’s skill set is the differentiating factor ... that of an IT professional that has clinical workflow ...
(Date:9/17/2014)... September 17, 2014 Lee Berman, a ... will be appearing on The Balancing Act® airing on ... episodes. , The segment will premiere on September 19 ... Balancing Act® airing on Lifetime Television®' with show host ... Funding Corp. for over a decade and is the ...
(Date:9/17/2014)... September 17, 2014 On October 1-2, ... to the lineup at Techmanity, a celebration of the ... generation of tech events,” Techmanity will host the best ... to join the ranks of Cisco, PayPal, Samsung, Silicon ... Silicon Valley Technology Conference. , Voom was created to ...
(Date:9/17/2014)... 17, 2014 Health.Verticalize, a healthcare marketing ... their health insurance options in the 2014 open enrollment ... , Moving forward Health Network will be ... company has intentionally remained out of the spotlight for ... a single website to its present position with dozens ...
(Date:9/17/2014)... ATLANTA, GA (PRWEB) September 17, 2014 ... Contact Center software, has launched Presence Suite 10.0, ... journey and improve the customer experience. , The ... autonomy and flexibility. Now supervisors can get a ... and understand who is contributing most and who ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4Health News:Lee Berman Will Appear On The Balancing Act® airing on Lifetime Television® 2Health News:Health and Wellness Startup Voom Announces Sponsorship at Techmanity 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 2Health News:Health.Verticalize Rebrands as Health Network After Growing to 15 Million Users in Less Than One Year 3Health News:Presence Technology’s 10.0 Release Drives Contact Center Web Supervisor Effectiveness While Reducing Operation Costs and Delivering Enterprise Grade Scalability 2
... at the University of Queensland in Australia have found a ... Pacific, to be safe and effective in reducing anxiety. , ... Psychopharmacology , the results of a world-first clinical trial ... in treating anxiety and improving mood. The Kava was prescribed ...
... older people to reduce their risk of developing heart ... D in the skin and older people are more ... the natural aging process and changes in lifestyle. , ... D deficiency is significantly associated with metabolic syndrome, a ...
... Move Health Reform ForwardWASHINGTON, May 11 Statement attributable ... health reform that provides coverage and high quality, affordable ... costs strain individual, business and government budgets, and projected ... AMA is committed to action to help achieve greater ...
... David Cornfield, MD, the chief of pulmonary, ... Children,s Hospital at Stanford, has been elected president ... http://www.newscom.com/cgi-bin/prnh/20090511/SF14213 )Beginning this month, Cornfield is leading ... a one-year term. "It,s a great honor to ...
... or have debt or access problems, study finds , , MONDAY, ... the economy began, women were more likely than men to ... they need. , So finds a report released Monday by ... half of women surveyed said they had problems getting care ...
... Solutions(TM) secures 24/7 physician access to serve offshore ... InPlace Medical Solutions, the first full-service offshore medical ... in the offshore medical industry - securing physician ... its clients. All services are provided by ...
Cached Medicine News:Health News:Research finds kava safe and effective 2Health News:Research says older people need more sun 2Health News:Packard/Stanford Physician to Lead Society for Pediatric Research 2Health News:Most Women Struggle With Rising Health Care Costs 2Health News:Most Women Struggle With Rising Health Care Costs 3Health News:The Doctor Is In, Around the Clock 2Health News:The Doctor Is In, Around the Clock 3
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... Entire Column of a 384 Well Plate at ... 384 well plates, you need a pipettor that ... exactly what you get with our 16-channel Impact ... Impact/Impact2), this innovation was specifically designed to allow ...
... an Entire Column of a 384 Well Plate ... with 384 well plates, you need a pipettor ... Thats exactly what you get with our 16-channel ... (see Impact/Impact2), this innovation was specifically designed to ...
Medicine Products: